<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01428323</url>
  </required_header>
  <id_info>
    <org_study_id>3.4529.10</org_study_id>
    <nct_id>NCT01428323</nct_id>
  </id_info>
  <brief_title>Study of the Aerosol Deposition With Vented and Unvented Jet Nebulizer in Healthy Subjets</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fonds National de la Recherche Scientifique</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open-vent jet nebulizers are frequently used to promote drug lung deposition but their
      clinical efficacy and indications are not clear.

      Our study aimed to compare inhaled mass, and lung deposition of amikacin by using a jet
      nebulizer (Sidestream) under two different configurations: vented and unvented coupled to a
      110 ml corrugated piece of tubing.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amikacin Urinatory excretion</measure>
    <time_frame>Each miction during 24 hours</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">7</enrollment>
  <condition>Aerosol Drug Therapy</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vented and Unvented Jet Nebulizer</intervention_name>
    <description>Nebulizers used with 500mg aminoglycosides in 4ml until One minute after the sputerring point.</description>
    <other_name>Nebulizer Type: Sidestream</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy Volunteers between 18 and 60 years old

        Exclusion Criteria:

          -  Smokers

          -  Pathological spirometry

          -  History of treatment with aminoglygosides 1 month prior the study

          -  Known allergy to aminoglycosydes

          -  Any lung pathology or history of lung surgery
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurent NP Pitance, PT</last_name>
    <phone>+3227645711</phone>
    <email>laurent.pitance@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Giusepe Liistro, MD</last_name>
    <phone>+3227642843</phone>
    <email>Giusepe.liistro@uclouvain.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Pitance, PT</last_name>
      <phone>+3227645702</phone>
      <email>laurent.pitance@uclouvain.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2011</study_first_submitted>
  <study_first_submitted_qc>September 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2011</study_first_posted>
  <last_update_submitted>September 1, 2011</last_update_submitted>
  <last_update_submitted_qc>September 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

